Treace Medical Concepts, Inc. (TMCI)

USD 7.1

(-6.7%)

Market Cap (In USD)

444.59 Million

Revenue (In USD)

187.11 Million

Net Income (In USD)

-49.52 Million

Avg. Volume

423.8 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
3.92-15.98
PE
-7.89
EPS
-0.9
Beta Value
0.24
ISIN
US89455T1097
CUSIP
89455T109
CIK
1630627
Shares
62618700.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Mr. John T. Treace
Employee Count
-
Website
https://www.treace.com
Ipo Date
2021-04-23
Details
Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement. The company also provides Lapiplasty Mini-Incision precision system. In addition, it offers products to address ancillary surgical procedures, including akin osteotomies, weil osteotomies, intercuneiform stabilization, lesser tarsometatarsal joint fusions, and autograft bone harvesting, as well as for MTP fusion. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra Beach, Florida.